An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer

Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms in individual people, here we present an omic and multidimens...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Cell reports. Medicine Ročník 3; číslo 2; s. 100525
Hlavní autori: Johnson, Brett E., Creason, Allison L., Stommel, Jayne M., Keck, Jamie M., Parmar, Swapnil, Betts, Courtney B., Blucher, Aurora, Boniface, Christopher, Bucher, Elmar, Burlingame, Erik, Camp, Todd, Chin, Koei, Eng, Jennifer, Estabrook, Joseph, Feiler, Heidi S., Heskett, Michael B., Hu, Zhi, Kolodzie, Annette, Kong, Ben L., Labrie, Marilyne, Lee, Jinho, Leyshock, Patrick, Mitri, Souraya, Patterson, Janice, Riesterer, Jessica L., Sivagnanam, Shamilene, Somers, Julia, Sudar, Damir, Thibault, Guillaume, Weeder, Benjamin R., Zheng, Christina, Nan, Xiaolin, Thompson, Reid F., Heiser, Laura M., Spellman, Paul T., Thomas, George, Demir, Emek, Chang, Young Hwan, Coussens, Lisa M., Guimaraes, Alexander R., Corless, Christopher, Goecks, Jeremy, Bergan, Raymond, Mitri, Zahi, Mills, Gordon B., Gray, Joe W.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Elsevier Inc 15.02.2022
Elsevier
Predmet:
ISSN:2666-3791, 2666-3791
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms in individual people, here we present an omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical metadata that includes treatment times and doses, anatomic imaging, and blood-based response measurements to clinical and exploratory analyses, which includes comprehensive DNA, RNA, and protein profiles; images of multiplexed immunostaining; and 2- and 3-dimensional scanning electron micrographs. These data report aspects of heterogeneity and evolution of the cancer genome, signaling pathways, immune microenvironment, cellular composition and organization, and ultrastructure. We present illustrative examples of how integrative analyses of these data reveal potential mechanisms of response and resistance and suggest novel therapeutic vulnerabilities. [Display omitted] •Safe and reliable workflows for multiplatform measurements from single biopsies•Clinical metadata with 11 omic and imaging assays from serial biopsy and blood•Omic, cellular, and structural evolution of metastatic cancer in a single individual•Integrative analyses reveal new potential mechanisms of response and resistance Identifying mechanisms of response and resistance to treatment in individual cancer patients is challenging but critical for improvement of precision medicine outcomes. Johnson et al. report a comprehensive atlas from a single individual with breast cancer and demonstrate how longitudinal, integrative analyses can provide new insights.
AbstractList Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms in individual people, here we present an omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical metadata that includes treatment times and doses, anatomic imaging, and blood-based response measurements to clinical and exploratory analyses, which includes comprehensive DNA, RNA, and protein profiles; images of multiplexed immunostaining; and 2- and 3-dimensional scanning electron micrographs. These data report aspects of heterogeneity and evolution of the cancer genome, signaling pathways, immune microenvironment, cellular composition and organization, and ultrastructure. We present illustrative examples of how integrative analyses of these data reveal potential mechanisms of response and resistance and suggest novel therapeutic vulnerabilities.Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms in individual people, here we present an omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical metadata that includes treatment times and doses, anatomic imaging, and blood-based response measurements to clinical and exploratory analyses, which includes comprehensive DNA, RNA, and protein profiles; images of multiplexed immunostaining; and 2- and 3-dimensional scanning electron micrographs. These data report aspects of heterogeneity and evolution of the cancer genome, signaling pathways, immune microenvironment, cellular composition and organization, and ultrastructure. We present illustrative examples of how integrative analyses of these data reveal potential mechanisms of response and resistance and suggest novel therapeutic vulnerabilities.
Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms in individual people, here we present an omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical metadata that includes treatment times and doses, anatomic imaging, and blood-based response measurements to clinical and exploratory analyses, which includes comprehensive DNA, RNA, and protein profiles; images of multiplexed immunostaining; and 2- and 3-dimensional scanning electron micrographs. These data report aspects of heterogeneity and evolution of the cancer genome, signaling pathways, immune microenvironment, cellular composition and organization, and ultrastructure. We present illustrative examples of how integrative analyses of these data reveal potential mechanisms of response and resistance and suggest novel therapeutic vulnerabilities.
Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms in individual people, here we present an omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical metadata that includes treatment times and doses, anatomic imaging, and blood-based response measurements to clinical and exploratory analyses, which includes comprehensive DNA, RNA, and protein profiles; images of multiplexed immunostaining; and 2- and 3-dimensional scanning electron micrographs. These data report aspects of heterogeneity and evolution of the cancer genome, signaling pathways, immune microenvironment, cellular composition and organization, and ultrastructure. We present illustrative examples of how integrative analyses of these data reveal potential mechanisms of response and resistance and suggest novel therapeutic vulnerabilities. [Display omitted] •Safe and reliable workflows for multiplatform measurements from single biopsies•Clinical metadata with 11 omic and imaging assays from serial biopsy and blood•Omic, cellular, and structural evolution of metastatic cancer in a single individual•Integrative analyses reveal new potential mechanisms of response and resistance Identifying mechanisms of response and resistance to treatment in individual cancer patients is challenging but critical for improvement of precision medicine outcomes. Johnson et al. report a comprehensive atlas from a single individual with breast cancer and demonstrate how longitudinal, integrative analyses can provide new insights.
SummaryMechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms in individual people, here we present an omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical metadata that includes treatment times and doses, anatomic imaging, and blood-based response measurements to clinical and exploratory analyses, which includes comprehensive DNA, RNA, and protein profiles; images of multiplexed immunostaining; and 2- and 3-dimensional scanning electron micrographs. These data report aspects of heterogeneity and evolution of the cancer genome, signaling pathways, immune microenvironment, cellular composition and organization, and ultrastructure. We present illustrative examples of how integrative analyses of these data reveal potential mechanisms of response and resistance and suggest novel therapeutic vulnerabilities.
Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during treatment. To support the development of methods for identifying these mechanisms in individual people, here we present an omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical metadata that includes treatment times and doses, anatomic imaging, and blood-based response measurements to clinical and exploratory analyses, which includes comprehensive DNA, RNA, and protein profiles; images of multiplexed immunostaining; and 2- and 3-dimensional scanning electron micrographs. These data report aspects of heterogeneity and evolution of the cancer genome, signaling pathways, immune microenvironment, cellular composition and organization, and ultrastructure. We present illustrative examples of how integrative analyses of these data reveal potential mechanisms of response and resistance and suggest novel therapeutic vulnerabilities. • Safe and reliable workflows for multiplatform measurements from single biopsies • Clinical metadata with 11 omic and imaging assays from serial biopsy and blood • Omic, cellular, and structural evolution of metastatic cancer in a single individual • Integrative analyses reveal new potential mechanisms of response and resistance Identifying mechanisms of response and resistance to treatment in individual cancer patients is challenging but critical for improvement of precision medicine outcomes. Johnson et al. report a comprehensive atlas from a single individual with breast cancer and demonstrate how longitudinal, integrative analyses can provide new insights.
ArticleNumber 100525
Author Kong, Ben L.
Demir, Emek
Stommel, Jayne M.
Lee, Jinho
Coussens, Lisa M.
Thibault, Guillaume
Sivagnanam, Shamilene
Thomas, George
Keck, Jamie M.
Mitri, Zahi
Labrie, Marilyne
Zheng, Christina
Chin, Koei
Thompson, Reid F.
Corless, Christopher
Blucher, Aurora
Creason, Allison L.
Heiser, Laura M.
Weeder, Benjamin R.
Chang, Young Hwan
Boniface, Christopher
Riesterer, Jessica L.
Burlingame, Erik
Mills, Gordon B.
Eng, Jennifer
Leyshock, Patrick
Somers, Julia
Spellman, Paul T.
Guimaraes, Alexander R.
Patterson, Janice
Sudar, Damir
Mitri, Souraya
Johnson, Brett E.
Goecks, Jeremy
Bergan, Raymond
Bucher, Elmar
Parmar, Swapnil
Camp, Todd
Heskett, Michael B.
Feiler, Heidi S.
Nan, Xiaolin
Hu, Zhi
Kolodzie, Annette
Estabrook, Joseph
Gray, Joe W.
Betts, Courtney B.
Author_xml – sequence: 1
  givenname: Brett E.
  orcidid: 0000-0001-6810-551X
  surname: Johnson
  fullname: Johnson, Brett E.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 2
  givenname: Allison L.
  orcidid: 0000-0001-5724-1276
  surname: Creason
  fullname: Creason, Allison L.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 3
  givenname: Jayne M.
  orcidid: 0000-0003-2485-7992
  surname: Stommel
  fullname: Stommel, Jayne M.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 4
  givenname: Jamie M.
  surname: Keck
  fullname: Keck, Jamie M.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 5
  givenname: Swapnil
  surname: Parmar
  fullname: Parmar, Swapnil
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 6
  givenname: Courtney B.
  surname: Betts
  fullname: Betts, Courtney B.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 7
  givenname: Aurora
  orcidid: 0000-0001-6460-010X
  surname: Blucher
  fullname: Blucher, Aurora
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 8
  givenname: Christopher
  orcidid: 0000-0003-0130-7517
  surname: Boniface
  fullname: Boniface, Christopher
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 9
  givenname: Elmar
  surname: Bucher
  fullname: Bucher, Elmar
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 10
  givenname: Erik
  surname: Burlingame
  fullname: Burlingame, Erik
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 11
  givenname: Todd
  surname: Camp
  fullname: Camp, Todd
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 12
  givenname: Koei
  surname: Chin
  fullname: Chin, Koei
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 13
  givenname: Jennifer
  surname: Eng
  fullname: Eng, Jennifer
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 14
  givenname: Joseph
  surname: Estabrook
  fullname: Estabrook, Joseph
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 15
  givenname: Heidi S.
  surname: Feiler
  fullname: Feiler, Heidi S.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 16
  givenname: Michael B.
  surname: Heskett
  fullname: Heskett, Michael B.
  organization: Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 17
  givenname: Zhi
  surname: Hu
  fullname: Hu, Zhi
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 18
  givenname: Annette
  orcidid: 0000-0002-9606-6500
  surname: Kolodzie
  fullname: Kolodzie, Annette
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 19
  givenname: Ben L.
  orcidid: 0000-0002-9019-6961
  surname: Kong
  fullname: Kong, Ben L.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 20
  givenname: Marilyne
  surname: Labrie
  fullname: Labrie, Marilyne
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 21
  givenname: Jinho
  surname: Lee
  fullname: Lee, Jinho
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 22
  givenname: Patrick
  surname: Leyshock
  fullname: Leyshock, Patrick
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 23
  givenname: Souraya
  surname: Mitri
  fullname: Mitri, Souraya
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 24
  givenname: Janice
  orcidid: 0000-0002-8969-2933
  surname: Patterson
  fullname: Patterson, Janice
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 25
  givenname: Jessica L.
  orcidid: 0000-0003-1084-2773
  surname: Riesterer
  fullname: Riesterer, Jessica L.
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 26
  givenname: Shamilene
  surname: Sivagnanam
  fullname: Sivagnanam, Shamilene
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 27
  givenname: Julia
  orcidid: 0000-0001-9489-2246
  surname: Somers
  fullname: Somers, Julia
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 28
  givenname: Damir
  orcidid: 0000-0002-2510-7272
  surname: Sudar
  fullname: Sudar, Damir
  organization: Quantitative Imaging Systems LLC, Portland, OR 97239, USA
– sequence: 29
  givenname: Guillaume
  surname: Thibault
  fullname: Thibault, Guillaume
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 30
  givenname: Benjamin R.
  surname: Weeder
  fullname: Weeder, Benjamin R.
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 31
  givenname: Christina
  surname: Zheng
  fullname: Zheng, Christina
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 32
  givenname: Xiaolin
  orcidid: 0000-0002-0597-0255
  surname: Nan
  fullname: Nan, Xiaolin
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 33
  givenname: Reid F.
  surname: Thompson
  fullname: Thompson, Reid F.
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 34
  givenname: Laura M.
  surname: Heiser
  fullname: Heiser, Laura M.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 35
  givenname: Paul T.
  surname: Spellman
  fullname: Spellman, Paul T.
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 36
  givenname: George
  orcidid: 0000-0001-7416-8840
  surname: Thomas
  fullname: Thomas, George
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 37
  givenname: Emek
  surname: Demir
  fullname: Demir, Emek
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 38
  givenname: Young Hwan
  orcidid: 0000-0001-8764-1959
  surname: Chang
  fullname: Chang, Young Hwan
  organization: Department of Biomedical Engineering, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 39
  givenname: Lisa M.
  orcidid: 0000-0003-2389-1865
  surname: Coussens
  fullname: Coussens, Lisa M.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 40
  givenname: Alexander R.
  surname: Guimaraes
  fullname: Guimaraes, Alexander R.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 41
  givenname: Christopher
  orcidid: 0000-0003-4871-8364
  surname: Corless
  fullname: Corless, Christopher
  organization: Department of Pharmacy Services, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 42
  givenname: Jeremy
  orcidid: 0000-0002-4583-5226
  surname: Goecks
  fullname: Goecks, Jeremy
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 43
  givenname: Raymond
  orcidid: 0000-0001-8690-4876
  surname: Bergan
  fullname: Bergan, Raymond
  organization: Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA
– sequence: 44
  givenname: Zahi
  surname: Mitri
  fullname: Mitri, Zahi
  organization: Division of Hematology & Medical Oncology, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 45
  givenname: Gordon B.
  surname: Mills
  fullname: Mills, Gordon B.
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
– sequence: 46
  givenname: Joe W.
  orcidid: 0000-0001-9225-6756
  surname: Gray
  fullname: Gray, Joe W.
  email: grayjo@ohsu.edu
  organization: Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35243422$$D View this record in MEDLINE/PubMed
BookMark eNqFUk1v1DAQtVARbZf-AQ7IRy67-CNxsghVqiq-pEocgLPl2JNlFsde7GRF_z1Ot1SlEuU0I3veG_u9d0qOQgxAyAvOVpxx9Xq7-mXTsBJMiHLAalE_ISdCKbWUzZof3euPyVnOW8aYqDlvJXtGjmUtKlkJcUI2F4HGAS01wdFh8iM6HCBkjMF4mndmxFLN6E2mfYoDzZDmkw7jLiNkGvsCpbCPfo9hQwcYTR4LytIuQWmpNcFCek6e9sZnOLutC_Lt_buvlx-XV58_fLq8uFraWvFx2Rpnu7Zqq65rRCWYqTvDqqY3ClTXKMl759ZW9o1grVj35TccuJN8LYUC2Tu5IOcH3t3UDeAshDEZr3cJB5OudTSo_74J-F1v4l63reLrhheCV7cEKf6cII96wGzBexMgTlkLJRWvVFPqgry8v-tuyR91y4A4DNgUc07Q341wpmcX9VbPLurZRX1wsYDaByCLs6Bxfi_6x6FvD1AoCu8Rks4WocjvMIEdtYv4OPz8Adx6DGiN_wHXkLdxSiUUWXOdhWb6y5ywOWBC3ISrLQRv_k3wv-2_AeMX4eg
CitedBy_id crossref_primary_10_1007_s12032_025_03028_1
crossref_primary_10_1038_s41568_025_00824_9
crossref_primary_10_1073_pnas_2322068121
crossref_primary_10_1093_mictod_qaaf026
crossref_primary_10_1111_boc_70006
crossref_primary_10_3389_fimmu_2023_1162905
crossref_primary_10_1002_pmic_202200402
crossref_primary_10_1093_micmic_ozad067_554
crossref_primary_10_1093_mam_ozae044_485
crossref_primary_10_3389_pore_2022_1610103
crossref_primary_10_1007_s10911_023_09540_2
crossref_primary_10_1038_s41587_022_01380_5
crossref_primary_10_3389_fonc_2022_998222
crossref_primary_10_1038_s41467_025_55914_x
crossref_primary_10_1038_s43586_022_00131_9
crossref_primary_10_1016_j_isci_2024_110668
crossref_primary_10_1186_s13058_025_01964_4
crossref_primary_10_1371_journal_pcbi_1010505
crossref_primary_10_3390_cancers14194885
Cites_doi 10.1093/biostatistics/kxj037
10.1200/JCO.2017.76.8671
10.1038/s41571-020-00460-2
10.1093/bioinformatics/btr509
10.3389/fonc.2019.00666
10.1186/s13058-016-0794-1
10.1038/s41586-019-1450-6
10.1242/jcs.023549
10.1007/978-1-4939-9773-2_24
10.1002/cyto.a.23726
10.1038/nature23465
10.1016/j.it.2015.02.008
10.1186/1471-2105-14-7
10.1158/0008-5472.CAN-15-0728
10.1038/s41423-018-0004-4
10.1056/NEJMoa041588
10.1093/bioinformatics/bts034
10.1093/nar/gky379
10.1016/j.apm.2019.02.036
10.1186/s12967-018-1733-y
10.1158/2159-8290.CD-15-0894
10.1016/j.cell.2020.03.053
10.1038/s41592-020-01018-x
10.1093/bioinformatics/btu548
10.1038/nature11412
10.1038/s41592-019-0686-2
10.1038/nmeth.1896
10.1093/bioinformatics/btp698
10.1039/C6MB00740F
10.1126/scitranslmed.aav7171
10.1042/BST20140145
10.1186/s13059-017-1382-0
10.1158/0008-5472.CAN-15-1654
10.1016/j.ccell.2020.03.009
10.1074/mcp.RA117.000291
10.1124/jpet.120.000309
10.1093/bioinformatics/bty633
10.1038/srep39259
10.1371/journal.pbio.1002340
10.1016/bs.mcb.2020.01.005
10.1038/s41467-017-00965-y
10.3389/fonc.2020.614288
10.18632/oncotarget.26947
10.18632/oncotarget.27877
10.1016/j.cels.2015.12.004
10.1126/sciadv.abb2210
10.1016/j.molimm.2018.03.025
10.1093/nar/gkv736
10.1016/j.freeradbiomed.2016.11.050
10.18632/oncotarget.3920
10.1039/c5ib00040h
10.1016/j.patter.2021.100257
10.1038/ncomms4887
10.1158/1078-0432.CCR-20-2114
10.1038/nprot.2014.170
10.1038/ncomms9390
10.1126/science.aaf1490
10.2174/18715281113126660060
10.1074/mcp.RA118.001260
10.1016/j.ccell.2018.08.008
10.1038/srep40766
10.1073/pnas.0408864102
10.1038/s41586-020-2308-7
10.1016/j.devcel.2016.02.012
10.2217/pgs-2017-0094
10.1200/JCO.2009.26.5983
10.1007/978-981-32-9755-5_14
10.1016/j.celrep.2017.03.037
10.1126/scitranslmed.aag1711
10.1371/journal.pbio.2005970
10.1186/1471-2105-12-71
10.1038/nature12138
10.1038/nrc.2016.52
10.1101/mcs.a003772
10.1038/s41591-019-0432-4
10.1016/j.cels.2018.05.014
10.1038/nbt.2931
10.12688/f1000research.7563.1
10.1371/journal.pone.0080908
10.1038/s41698-021-00165-4
10.1093/nar/gky955
10.1158/1078-0432.CCR-17-3490
10.1038/s41598-018-27649-x
10.1038/s41598-019-41695-z
10.18632/oncotarget.27127
10.1038/nbt.3519
10.1126/science.aao4227
10.3390/ijms21155497
10.1038/s41388-019-0695-8
10.1200/JCO.2015.61.5997
10.1016/j.chembiol.2019.05.005
10.1016/j.ejca.2008.10.026
10.1158/1535-7163.MCT-06-0334
10.1016/bs.mie.2019.05.039
10.1016/j.ejca.2015.10.014
10.1200/JCO.2008.18.1370
10.3390/diagnostics11010073
10.1073/pnas.95.25.14863
10.1093/bioinformatics/btz653
10.1016/j.cviu.2007.09.014
10.2967/jnumed.118.209544
10.1016/j.ccell.2018.01.021
10.1158/0008-5472.CAN-05-2925
10.1093/bioinformatics/bth349
10.1126/scisignal.2001426
10.1371/journal.pcbi.1004873
10.1093/nar/gkq1039
10.1038/nmeth.2089
10.1093/nar/gkz433
10.1101/gr.107524.110
10.1016/j.cell.2015.06.017
ContentType Journal Article
Copyright 2022 The Authors
The Authors
2022 The Authors.
2022 The Authors 2022
Copyright_xml – notice: 2022 The Authors
– notice: The Authors
– notice: 2022 The Authors.
– notice: 2022 The Authors 2022
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1016/j.xcrm.2022.100525
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE




Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2666-3791
EndPage 100525
ExternalDocumentID PMC8861971
35243422
10_1016_j_xcrm_2022_100525
S2666379122000258
1_s2_0_S2666379122000258
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIGMS NIH HHS
  grantid: R01 GM132322
– fundername: NCI NIH HHS
  grantid: U54 CA209988
– fundername: NCI NIH HHS
  grantid: P30 CA069533
– fundername: NCI NIH HHS
  grantid: U01 CA217842
– fundername: NCI NIH HHS
  grantid: R44 CA224994
– fundername: NCI NIH HHS
  grantid: U2C CA233280
– fundername: NCI NIH HHS
  grantid: U01 CA224012
GroupedDBID .1-
.FO
0R~
53G
AAEDW
AALRI
AAMRU
AAXUO
AAYWO
ACVFH
ADCNI
ADVLN
AEUPX
AFPUW
AFRHN
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
EBS
FDB
GROUPED_DOAJ
M41
M~E
OK1
ROL
RPM
Z5R
AAHOK
NCXOZ
6I.
AAFTH
ACHIH
AFCTW
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c561t-8adcb8484bb72420a5ba047fa6e6b7631fdd9c3f720829f8301e1d319326e3fd3
ISICitedReferencesCount 29
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000759407600003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2666-3791
IngestDate Tue Sep 30 16:38:19 EDT 2025
Thu Jul 10 23:42:06 EDT 2025
Mon Jul 21 05:59:47 EDT 2025
Thu Nov 20 00:32:35 EST 2025
Tue Nov 18 22:14:03 EST 2025
Tue Jul 25 20:59:20 EDT 2023
Sun Feb 23 10:18:53 EST 2025
Tue Aug 26 19:32:32 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords precision oncology
human tumor atlas
metastatic breast cancer
personalized medicine
Language English
License This is an open access article under the CC BY license.
2022 The Authors.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c561t-8adcb8484bb72420a5ba047fa6e6b7631fdd9c3f720829f8301e1d319326e3fd3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Lead contact
ORCID 0000-0002-4583-5226
0000-0001-9489-2246
0000-0002-9606-6500
0000-0002-9019-6961
0000-0001-8764-1959
0000-0003-2389-1865
0000-0001-8690-4876
0000-0003-1084-2773
0000-0003-2485-7992
0000-0001-6460-010X
0000-0003-4871-8364
0000-0001-9225-6756
0000-0003-0130-7517
0000-0001-5724-1276
0000-0002-2510-7272
0000-0001-6810-551X
0000-0001-7416-8840
0000-0002-0597-0255
0000-0002-8969-2933
OpenAccessLink http://dx.doi.org/10.1016/j.xcrm.2022.100525
PMID 35243422
PQID 2636146726
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8861971
proquest_miscellaneous_2636146726
pubmed_primary_35243422
crossref_primary_10_1016_j_xcrm_2022_100525
crossref_citationtrail_10_1016_j_xcrm_2022_100525
elsevier_sciencedirect_doi_10_1016_j_xcrm_2022_100525
elsevier_clinicalkeyesjournals_1_s2_0_S2666379122000258
elsevier_clinicalkey_doi_10_1016_j_xcrm_2022_100525
PublicationCentury 2000
PublicationDate 2022-02-15
PublicationDateYYYYMMDD 2022-02-15
PublicationDate_xml – month: 02
  year: 2022
  text: 2022-02-15
  day: 15
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Cell reports. Medicine
PublicationTitleAlternate Cell Rep Med
PublicationYear 2022
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Stringer, Wang, Michaelos, Pachitariu (bib117) 2021; 18
Labrie, Fang, Kendsersky, Li, Liang, Westin, Mitri, Mills (bib20) 2019; 1188
Kurland, Peterson, Shields, Lee, Byrd, Novakova-Jiresova, Muzi, Specht, Mankoff, Linden (bib86) 2019; 60
Merker, Oxnard, Compton, Diehn, Hurley, Lazar, Lindeman, Lockwood, Rai, Schilsky (bib77) 2018; 36
Ethier, Desautels, Templeton, Shah, Amir (bib37) 2017; 19
Peixoto, Risso, Poplawski, Wimmer, Speed, Wood, Abel (bib104) 2015; 43
Afgan, Baker, Batut, van den Beek, Bouvier, Cech, Chilton, Clements, Coraor, Gruning (bib75) 2018; 46
(bib16) 2012; 490
Sherr, Beach, Shapiro (bib52) 2016; 6
Riesterer, Stempinski, Lopez (bib79) 2019
Barros, Hauck, Dreyer, Kempkes, Niedobitek (bib30) 2013; 8
Talevich, Shain, Botton, Bastian (bib92) 2016; 12
McCartney, Migliaccio, Bonechi, Biagioni, Romagnoli, De Luca, Galardi, Risi, De Santo, Benelli (bib48) 2019; 9
Eng (bib115) 2021
Li, Durbin (bib87) 2010; 26
Szolek, Schubert, Mohr, Sturm, Feldhahn, Kohlbacher (bib94) 2014; 30
Akbani, Ng, Werner, Shahmoradgoli, Zhang, Ju, Liu, Yang, Yoshihara, Li (bib108) 2014; 5
Yoon, Kim, Goo, Kim, Hahn (bib85) 2016; 53
Bandola-Simon, Roche (bib65) 2019; 113
Johnson, Li, Rabinovic (bib118) 2007; 8
O'Reilly, Rojo, She, Solit, Mills, Smith, Lane, Hofmann, Hicklin, Ludwig (bib50) 2006; 66
Llanos, Megias, Blanco-Aparicio, Hernandez-Encinas, Rovira, Pietrocola, Serrano (bib68) 2019; 38
Albrengues, Shields, Ng, Park, Ambrico, Poindexter, Upadhyay, Uyeminami, Pommier, Kuttner (bib34) 2018; 361
Acerbi, Cassereau, Dean, Shi, Au, Park, Chen, Liphardt, Hwang, Weaver (bib60) 2015; 7
Chen, Li, Wang, Akbani, Lu, Mills, Liang (bib19) 2019; 18
Blass, Ott (bib13) 2021; 18
Babur, Luna, Korkut, Durupinar, Siper, Dogrusoz, Vaca Jacome, Peckner, Christianson, Jaffe (bib25) 2021; 2
Sivagnanam, Betts, Coussens (bib112) 2021
Dogruluk, Tsang, Espitia, Chen, Chen, Chong, Appadurai, Dogruluk, Eterovic, Bonnen (bib9) 2015; 75
Marangoni, Laurent, Coussy, El-Botty, Chateau-Joubert, Servely, de Plater, Assayag, Dahmani, Montaudon (bib57) 2018; 24
Iida, Nakamura, Tokuda, Toyosawa, Niwa, Ohuchi, Ishida, Hayashi (bib54) 2019; 10
McGranahan, Furness, Rosenthal, Ramskov, Lyngaa, Saini, Jamal-Hanjani, Wilson, Birkbak, Hiley (bib12) 2016; 351
Karczewski, Francioli, Tiao, Cummings, Alfoldi, Wang, Collins, Laricchia, Ganna, Birnbaum (bib89) 2020; 581
Li, Keck, Parmar, Patterson, Labrie, Creason, Johnson, Downey, Thomas, Beadling (bib71) 2021; 5
Parker, Mullins, Cheang, Leung, Voduc, Vickery, Davies, Fauron, He, Hu (bib15) 2009; 27
Riesterer, Lopez, Stempinski, Williams, Loftis, Stoltz, Thibault, Lanicault, Williams, Gray (bib41) 2020; 158
Saha, Kim, Amaya, Witcher, Khammanivong, Korpela, Brown, Taylor, Bryan, Dickerson (bib70) 2020; 10
Coffelt, Wellenstein, de Visser (bib36) 2016; 16
Fassl, Brain, Abu-Remaileh, Stukan, Butter, Stepien, Feit, Bergholz, Michowski, Otto (bib67) 2020; 6
Saki, Prakash (bib63) 2017; 107
Labrie, Kim, Ju, Lee, Zhao, Fang, Lu, Chen, Ramirez, Frumovitz (bib22) 2019; 10
Schwaederle, Zhao, Lee, Eggermont, Schilsky, Mendelsohn, Lazar, Kurzrock (bib2) 2015; 33
Ahmad, Rajabi, Kosugi, Joshi, Alam, Vasir, Kawano, Kharbanda, Kufe (bib26) 2011; 4
(bib121) 2019
Tsujikawa, Kumar, Borkar, Azimi, Thibault, Chang, Balter, Kawashima, Choe, Sauer (bib28) 2017; 19
Young Hwan, Thibault, Madin, Azimi, Meyers, Johnson, Link, Margolin, Gray (bib116) 2017; 2017
Bardia, Hurvitz, DeMichele, Clark, Zelnak, Yardley, Karuturi, Sanft, Blau, Hart (bib72) 2021; 27
Saldanha (bib109) 2004; 20
Palm, Park, Wright, Pavlova, Tuveson, Thompson (bib64) 2015; 162
Park, Wysocki, Amoozgar, Maiorino, Fein, Jorns, Schott, Kinugasa-Katayama, Lee, Won (bib35) 2016; 8
Collins, Witta, Coy, Pang, Gustafson (bib69) 2021; 376
Nelson, Piehler, Eckels, Rauch, Bellew, Hussey, Ramsay, Nathe, Lum, Krouse (bib74) 2011; 12
Hanzelmann, Castelo, Guinney (bib17) 2013; 14
Edelstein, Amodaj, Hoover, Vale, Stuurman (bib83) 2010; Chapter 14
Riesterer, Stempinski, Lopez (bib78) 2020
Montoya, GF, González-Sánchez (bib98) 2019; 71
Traag, Waltman, van Eck (bib120) 2019; 9
Eng, Thibault, Luoh, Gray, Chang, Chin (bib39) 2020; 2055
Paik, Shak, Tang, Kim, Baker, Cronin, Baehner, Walker, Watson, Park (bib6) 2004; 351
Buechler, Eisinger, Krautbauer (bib32) 2013; 12
Boniface, Deig, Halsey, Kelley, Heskett, Thomas, Spellman, Nabavizadeh (bib97) 2021; 11
Hosios, Hecht, Danai, Johnson, Rathmell, Steinhauser, Manalis, Vander Heiden (bib45) 2016; 36
O'Donnell, Rubinsteyn, Bonsack, Riemer, Laserson, Hammerbacher (bib95) 2018; 7
Leek, Johnson, Parker, Jaffe, Storey (bib106) 2012; 28
Kang, Bader, Vogt (bib51) 2005; 102
Risso, Ngai, Speed, Dudoit (bib105) 2014; 32
Bay, Ess, Tuytelaars, Van Gool (bib113) 2008; 110
Sanchez, Mills, Mills Shaw (bib3) 2017; 18
Adalsteinsson, Ha, Freeman, Choudhury, Stover, Parsons, Gydush, Reed, Rotem, Rhoades (bib99) 2017; 8
Von Hoff, Stephenson, Rosen, Loesch, Borad, Anthony, Jameson, Brown, Cantafio, Richards (bib1) 2010; 28
Wolf, Angerer, Theis (bib119) 2018; 19
Lin, Fallahi-Sichani, Sorger (bib40) 2015; 6
Lee, Geiss, Demirkan, Vellano, Filanoski, Lu, Ju, Yu, Guo, Bogatzki (bib23) 2018; 17
Cerami, Gross, Demir, Rodchenkov, Babur, Anwar, Schultz, Bader, Sander (bib24) 2011; 39
Kennedy, Schmitt, Fox, Kohrn, Salk, Ahn, Prindle, Kuong, Shen, Risques (bib96) 2014; 9
Desir, O'Hare, Vogel, Sperduto, Sarkari, Dickson, Wong, Nelson, Fong, Steer (bib61) 2018; 8
Banik, Betts, Liudahl, Sivagnanam, Kawashima, Cotechini, Larson, Goecks, Pai, Clayburgh (bib27) 2020; 635
Soneson, Love, Robinson (bib103) 2015; 4
Hafner, Mills, Subramanian, Chen, Chung, Boswell, Everley, Liu, Walmsley, Juric (bib56) 2019; 26
Villamil Giraldo, Appelqvist, Ederth, Ollinger (bib66) 2014; 42
Creech, Wang, Nan, Gibbs (bib43) 2017; 7
Tatlow, Piccolo (bib100) 2016; 6
Razavi, Chang, Xu, Bandlamudi, Ross, Vasan, Cai, Bielski, Donoghue, Jonsson (bib46) 2018; 34
Nickerson, Huang, Lin, Nan (bib84) 2015; 106
Commisso, Davidson, Soydaner-Azeloglu, Parker, Kamphorst, Hackett, Grabocka, Nofal, Drebin, Thompson (bib44) 2013; 497
O'Meara, Tolaney (bib11) 2021; 12
Frankish, Diekhans, Ferreira, Johnson, Jungreis, Loveland, Mudge, Sisu, Wright, Armstrong (bib102) 2019; 47
bib7
Belevich, Joensuu, Kumar, Vihinen, Jokitalo (bib82) 2016; 14
Wood, Nguyen, Struck, Ellrott, Nellore, Thompson (bib93) 2020; 36
Rozenblatt-Rosen, Regev, Oberdoerffer, Nawy, Hupalowska, Rood, Ashenberg, Cerami, Coffey, Demir (bib5) 2020; 181
Ogawa, Baserga (bib62) 2017; 13
Knochelmann, Dwyer, Bailey, Amaya, Elston, Mazza-McCrann, Paulos (bib58) 2018; 15
Liberzon, Birger, Thorvaldsdottir, Ghandi, Mesirov, Tamayo (bib18) 2015; 1
Tibes, Qiu, Lu, Hennessy, Andreeff, Mills, Kornblau (bib21) 2006; 5
Skytthe, Graversen, Moestrup (bib31) 2020; 21
Molania, Gagnon-Bartsch, Dobrovic, Speed (bib111) 2019; 47
Bray, Pimentel, Melsted, Pachter (bib101) 2016; 34
Voorwerk, Slagter, Horlings, Sikorska, van de Vijver, de Maaker, Nederlof, Kluin, Warren, Ong (bib73) 2019; 25
McQuin, Goodman, Chernyshev, Kamentsky, Cimini, Karhohs, Doan, Ding, Rafelski, Thirstrup (bib114) 2018; 16
Allan, Burel, Moore, Blackburn, Linkert, Loynton, Macdonald, Moore, Neves, Patterson (bib76) 2012; 9
Paradis, Schliep (bib91) 2019; 35
Kerber, Cheney (bib42) 2011; 124
Mi, Ye, Liu, She (bib49) 2015; 6
Hanker, Sudhan, Arteaga (bib47) 2020; 37
Mitri, Parmar, Johnson, Kolodzie, Keck, Morris, Guimaraes, Beckett, Borate, Lopez (bib4) 2018; 16
Pauken, Wherry (bib33) 2015; 36
Herrera-Abreu, Palafox, Asghar, Rivas, Cutts, Garcia-Murillas, Pearson, Guzman, Rodriguez, Grueso (bib53) 2016; 76
Goel, DeCristo, Watt, BrinJones, Sceneay, Li, Khan, Ubellacker, Xie, Metzger-Filho (bib59) 2017; 548
Riesterer, Stempinski, Lopez (bib80) 2020
Li (bib90) 2011; 27
Jassal, Matthews, Viteri, Gong, Lorente, Fabregat, Sidiropoulos, Cook, Gillespie, Haw (bib107) 2020; 48
Eisen, Spellman, Brown, Botstein (bib110) 1998; 95
Wellenstein, Coffelt, Duits, van Miltenburg, Slagter, de Rink, Henneman, Kas, Prekovic, Hau (bib38) 2019; 572
Schneider, Rasband, Eliceiri (bib81) 2012; 9
Virtanen, Gommers, Oliphant, Haberland, Reddy, Cournapeau, Burovski, Peterson, Weckesser, Bright (bib122) 2020; 17
Tsujikawa, Thibault, Azimi, Sivagnanam, Banik, Means, Kawashima, Clayburgh, Gray, Coussens (bib29) 2019; 95
Ng, Li, Jeong, Shao, Chen, Tsang, Sengupta, Wang, Bhavana, Tran (bib10) 2018; 33
Butler, Boniface, Johnson-Camacho, Tabatabaei, Melendez, Kelley, Gray, Corless, Spellman (bib14) 2019; 5
McKenna, Hanna, Banks, Sivachenko, Cibulskis, Kernytsky, Garimella, Altshuler, Gabriel, Daly (bib88) 2010; 20
Vilgelm, Saleh, Shattuck-Brandt, Riemenschneider, Slesur, Chen, Johnson, Yang, Blevins, Yan (bib55) 2019; 11
Eisenhauer, Therasse, Bogaerts, Schwartz, Sargent, Ford, Dancey, Arbuck, Gwyther, Mooney (bib8) 2009; 45
Paradis (10.1016/j.xcrm.2022.100525_bib91) 2019; 35
Mi (10.1016/j.xcrm.2022.100525_bib49) 2015; 6
Li (10.1016/j.xcrm.2022.100525_bib71) 2021; 5
Eisenhauer (10.1016/j.xcrm.2022.100525_bib8) 2009; 45
Banik (10.1016/j.xcrm.2022.100525_bib27) 2020; 635
O'Reilly (10.1016/j.xcrm.2022.100525_bib50) 2006; 66
Boniface (10.1016/j.xcrm.2022.100525_bib97) 2021; 11
Hafner (10.1016/j.xcrm.2022.100525_bib56) 2019; 26
Peixoto (10.1016/j.xcrm.2022.100525_bib104) 2015; 43
Paik (10.1016/j.xcrm.2022.100525_bib6) 2004; 351
Riesterer (10.1016/j.xcrm.2022.100525_bib79) 2019
Talevich (10.1016/j.xcrm.2022.100525_bib92) 2016; 12
Kennedy (10.1016/j.xcrm.2022.100525_bib96) 2014; 9
Hanzelmann (10.1016/j.xcrm.2022.100525_bib17) 2013; 14
Kerber (10.1016/j.xcrm.2022.100525_bib42) 2011; 124
Mitri (10.1016/j.xcrm.2022.100525_bib4) 2018; 16
O'Donnell (10.1016/j.xcrm.2022.100525_bib95) 2018; 7
Schneider (10.1016/j.xcrm.2022.100525_bib81) 2012; 9
Riesterer (10.1016/j.xcrm.2022.100525_bib80) 2020
Nickerson (10.1016/j.xcrm.2022.100525_bib84) 2015; 106
Tsujikawa (10.1016/j.xcrm.2022.100525_bib28) 2017; 19
Lin (10.1016/j.xcrm.2022.100525_bib40) 2015; 6
Virtanen (10.1016/j.xcrm.2022.100525_bib122) 2020; 17
Ethier (10.1016/j.xcrm.2022.100525_bib37) 2017; 19
Risso (10.1016/j.xcrm.2022.100525_bib105) 2014; 32
Knochelmann (10.1016/j.xcrm.2022.100525_bib58) 2018; 15
McCartney (10.1016/j.xcrm.2022.100525_bib48) 2019; 9
Stringer (10.1016/j.xcrm.2022.100525_bib117) 2021; 18
Johnson (10.1016/j.xcrm.2022.100525_bib118) 2007; 8
Eng (10.1016/j.xcrm.2022.100525_bib39) 2020; 2055
Ng (10.1016/j.xcrm.2022.100525_bib10) 2018; 33
Hosios (10.1016/j.xcrm.2022.100525_bib45) 2016; 36
Albrengues (10.1016/j.xcrm.2022.100525_bib34) 2018; 361
Desir (10.1016/j.xcrm.2022.100525_bib61) 2018; 8
Frankish (10.1016/j.xcrm.2022.100525_bib102) 2019; 47
Leek (10.1016/j.xcrm.2022.100525_bib106) 2012; 28
Sherr (10.1016/j.xcrm.2022.100525_bib52) 2016; 6
Skytthe (10.1016/j.xcrm.2022.100525_bib31) 2020; 21
Sivagnanam (10.1016/j.xcrm.2022.100525_bib112) 2021
Kang (10.1016/j.xcrm.2022.100525_bib51) 2005; 102
Tatlow (10.1016/j.xcrm.2022.100525_bib100) 2016; 6
Riesterer (10.1016/j.xcrm.2022.100525_bib78) 2020
Bandola-Simon (10.1016/j.xcrm.2022.100525_bib65) 2019; 113
Liberzon (10.1016/j.xcrm.2022.100525_bib18) 2015; 1
Riesterer (10.1016/j.xcrm.2022.100525_bib41) 2020; 158
Belevich (10.1016/j.xcrm.2022.100525_bib82) 2016; 14
Babur (10.1016/j.xcrm.2022.100525_bib25) 2021; 2
Creech (10.1016/j.xcrm.2022.100525_bib43) 2017; 7
Palm (10.1016/j.xcrm.2022.100525_bib64) 2015; 162
Nelson (10.1016/j.xcrm.2022.100525_bib74) 2011; 12
Eng (10.1016/j.xcrm.2022.100525_bib115)
Traag (10.1016/j.xcrm.2022.100525_bib120) 2019; 9
Lee (10.1016/j.xcrm.2022.100525_bib23) 2018; 17
Tsujikawa (10.1016/j.xcrm.2022.100525_bib29) 2019; 95
Sanchez (10.1016/j.xcrm.2022.100525_bib3) 2017; 18
Rozenblatt-Rosen (10.1016/j.xcrm.2022.100525_bib5) 2020; 181
Fassl (10.1016/j.xcrm.2022.100525_bib67) 2020; 6
Merker (10.1016/j.xcrm.2022.100525_bib77) 2018; 36
Blass (10.1016/j.xcrm.2022.100525_bib13) 2021; 18
Karczewski (10.1016/j.xcrm.2022.100525_bib89) 2020; 581
Montoya (10.1016/j.xcrm.2022.100525_bib98) 2019; 71
Schwaederle (10.1016/j.xcrm.2022.100525_bib2) 2015; 33
Marangoni (10.1016/j.xcrm.2022.100525_bib57) 2018; 24
Tibes (10.1016/j.xcrm.2022.100525_bib21) 2006; 5
Hanker (10.1016/j.xcrm.2022.100525_bib47) 2020; 37
Labrie (10.1016/j.xcrm.2022.100525_bib22) 2019; 10
Chen (10.1016/j.xcrm.2022.100525_bib19) 2019; 18
Cerami (10.1016/j.xcrm.2022.100525_bib24) 2011; 39
Von Hoff (10.1016/j.xcrm.2022.100525_bib1) 2010; 28
Park (10.1016/j.xcrm.2022.100525_bib35) 2016; 8
Dogruluk (10.1016/j.xcrm.2022.100525_bib9) 2015; 75
Goel (10.1016/j.xcrm.2022.100525_bib59) 2017; 548
McQuin (10.1016/j.xcrm.2022.100525_bib114) 2018; 16
Llanos (10.1016/j.xcrm.2022.100525_bib68) 2019; 38
Saki (10.1016/j.xcrm.2022.100525_bib63) 2017; 107
Szolek (10.1016/j.xcrm.2022.100525_bib94) 2014; 30
McKenna (10.1016/j.xcrm.2022.100525_bib88) 2010; 20
(10.1016/j.xcrm.2022.100525_bib16) 2012; 490
Soneson (10.1016/j.xcrm.2022.100525_bib103) 2015; 4
Iida (10.1016/j.xcrm.2022.100525_bib54) 2019; 10
Adalsteinsson (10.1016/j.xcrm.2022.100525_bib99) 2017; 8
Bardia (10.1016/j.xcrm.2022.100525_bib72) 2021; 27
Allan (10.1016/j.xcrm.2022.100525_bib76) 2012; 9
Pauken (10.1016/j.xcrm.2022.100525_bib33) 2015; 36
Wolf (10.1016/j.xcrm.2022.100525_bib119) 2018; 19
McGranahan (10.1016/j.xcrm.2022.100525_bib12) 2016; 351
Akbani (10.1016/j.xcrm.2022.100525_bib108) 2014; 5
Eisen (10.1016/j.xcrm.2022.100525_bib110) 1998; 95
Kurland (10.1016/j.xcrm.2022.100525_bib86) 2019; 60
Saha (10.1016/j.xcrm.2022.100525_bib70) 2020; 10
Commisso (10.1016/j.xcrm.2022.100525_bib44) 2013; 497
Li (10.1016/j.xcrm.2022.100525_bib87) 2010; 26
Parker (10.1016/j.xcrm.2022.100525_bib15) 2009; 27
Bray (10.1016/j.xcrm.2022.100525_bib101) 2016; 34
Barros (10.1016/j.xcrm.2022.100525_bib30) 2013; 8
Voorwerk (10.1016/j.xcrm.2022.100525_bib73) 2019; 25
Razavi (10.1016/j.xcrm.2022.100525_bib46) 2018; 34
Afgan (10.1016/j.xcrm.2022.100525_bib75) 2018; 46
Ahmad (10.1016/j.xcrm.2022.100525_bib26) 2011; 4
Coffelt (10.1016/j.xcrm.2022.100525_bib36) 2016; 16
Labrie (10.1016/j.xcrm.2022.100525_bib20) 2019; 1188
(10.1016/j.xcrm.2022.100525_bib121) 2019
O'Meara (10.1016/j.xcrm.2022.100525_bib11) 2021; 12
Acerbi (10.1016/j.xcrm.2022.100525_bib60) 2015; 7
Yoon (10.1016/j.xcrm.2022.100525_bib85) 2016; 53
Herrera-Abreu (10.1016/j.xcrm.2022.100525_bib53) 2016; 76
Molania (10.1016/j.xcrm.2022.100525_bib111) 2019; 47
Young Hwan (10.1016/j.xcrm.2022.100525_bib116) 2017; 2017
Saldanha (10.1016/j.xcrm.2022.100525_bib109) 2004; 20
Ogawa (10.1016/j.xcrm.2022.100525_bib62) 2017; 13
Collins (10.1016/j.xcrm.2022.100525_bib69) 2021; 376
Li (10.1016/j.xcrm.2022.100525_bib90) 2011; 27
Wellenstein (10.1016/j.xcrm.2022.100525_bib38) 2019; 572
Vilgelm (10.1016/j.xcrm.2022.100525_bib55) 2019; 11
Villamil Giraldo (10.1016/j.xcrm.2022.100525_bib66) 2014; 42
Edelstein (10.1016/j.xcrm.2022.100525_bib83) 2010; Chapter 14
Butler (10.1016/j.xcrm.2022.100525_bib14) 2019; 5
Buechler (10.1016/j.xcrm.2022.100525_bib32) 2013; 12
Wood (10.1016/j.xcrm.2022.100525_bib93) 2020; 36
Bay (10.1016/j.xcrm.2022.100525_bib113) 2008; 110
Jassal (10.1016/j.xcrm.2022.100525_bib107) 2020; 48
35243426 - Cell Rep Med. 2022 Feb 15;3(2):100532. doi: 10.1016/j.xcrm.2022.100532
References_xml – volume: 38
  start-page: 3886
  year: 2019
  end-page: 3902
  ident: bib68
  article-title: Lysosomal trapping of palbociclib and its functional implications
  publication-title: Oncogene
– volume: 47
  start-page: 6073
  year: 2019
  end-page: 6083
  ident: bib111
  article-title: A new normalization for Nanostring nCounter gene expression data
  publication-title: Nucleic Acids Res.
– volume: 19
  start-page: 2
  year: 2017
  ident: bib37
  article-title: Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
  publication-title: Breast Cancer Res.
– volume: 18
  start-page: 215
  year: 2021
  end-page: 229
  ident: bib13
  article-title: Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
  publication-title: Nat. Rev. Clin. Oncol.
– volume: 14
  start-page: 7
  year: 2013
  ident: bib17
  article-title: GSVA: gene set variation analysis for microarray and RNA-seq data
  publication-title: BMC Bioinformatics
– volume: 8
  start-page: 9484
  year: 2018
  ident: bib61
  article-title: Chemotherapy-induced tunneling nanotubes mediate intercellular drug efflux in pancreatic cancer
  publication-title: Sci. Rep.
– volume: 42
  start-page: 1460
  year: 2014
  end-page: 1464
  ident: bib66
  article-title: Lysosomotropic agents: impact on lysosomal membrane permeabilization and cell death
  publication-title: Biochem. Soc. Trans.
– volume: 110
  start-page: 346
  year: 2008
  end-page: 359
  ident: bib113
  article-title: Speeded-up robust features (SURF)
  publication-title: Comput. Vis. Image Understand.
– volume: 27
  start-page: 4177
  year: 2021
  end-page: 4185
  ident: bib72
  article-title: Phase I/II trial of exemestane, ribociclib, and everolimus in women with HR(+)/HER2(-) advanced breast cancer after progression on CDK4/6 inhibitors (TRINITI-1)
  publication-title: Clin. Cancer Res.
– volume: 18
  start-page: 100
  year: 2021
  end-page: 106
  ident: bib117
  article-title: Cellpose: a generalist algorithm for cellular segmentation
  publication-title: Nat. Methods
– volume: 43
  start-page: 7664
  year: 2015
  end-page: 7674
  ident: bib104
  article-title: How data analysis affects power, reproducibility and biological insight of RNA-seq studies in complex datasets
  publication-title: Nucleic Acids Res.
– volume: 34
  start-page: 427
  year: 2018
  end-page: 438.e426
  ident: bib46
  article-title: The genomic landscape of endocrine-resistant advanced breast cancers
  publication-title: Cancer Cell
– volume: 25
  start-page: 920
  year: 2019
  end-page: 928
  ident: bib73
  article-title: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
  publication-title: Nat. Med.
– volume: 9
  start-page: 666
  year: 2019
  ident: bib48
  article-title: Mechanisms of resistance to CDK4/6 inhibitors: potential implications and biomarkers for clinical practice
  publication-title: Front. Oncol.
– volume: 1
  start-page: 417
  year: 2015
  end-page: 425
  ident: bib18
  article-title: The Molecular Signatures Database (MSigDB) hallmark gene set collection
  publication-title: Cell Syst.
– volume: 7
  start-page: 129
  year: 2018
  end-page: 132.e124
  ident: bib95
  article-title: MHCflurry: open-source class I MHC binding affinity prediction
  publication-title: Cell Syst.
– volume: 7
  start-page: 1120
  year: 2015
  end-page: 1134
  ident: bib60
  article-title: Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration
  publication-title: Integr. Biol.
– volume: 6
  start-page: 353
  year: 2016
  end-page: 367
  ident: bib52
  article-title: Targeting CDK4 and CDK6: from discovery to therapy
  publication-title: Cancer Discov.
– volume: 9
  start-page: 5233
  year: 2019
  ident: bib120
  article-title: From Louvain to Leiden: guaranteeing well-connected communities
  publication-title: Sci. Rep.
– year: 2020
  ident: bib80
  article-title: 2D and 3D electron microscopy (EM) imaging of tissue biopsies and resections
– volume: 13
  start-page: 443
  year: 2017
  end-page: 455
  ident: bib62
  article-title: Crosstalk between the nucleolus and the DNA damage response
  publication-title: Mol. Biosyst.
– volume: 47
  start-page: D766
  year: 2019
  end-page: D773
  ident: bib102
  article-title: GENCODE reference annotation for the human and mouse genomes
  publication-title: Nucleic Acids Res.
– volume: 361
  start-page: eaao4227
  year: 2018
  ident: bib34
  article-title: Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
  publication-title: Science
– volume: 102
  start-page: 802
  year: 2005
  end-page: 807
  ident: bib51
  article-title: Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
  publication-title: Proc. Natl. Acad. Sci. U S A
– volume: 581
  start-page: 434
  year: 2020
  end-page: 443
  ident: bib89
  article-title: The mutational constraint spectrum quantified from variation in 141,456 humans
  publication-title: Nature
– volume: 12
  start-page: 71
  year: 2011
  ident: bib74
  article-title: LabKey Server: an open source platform for scientific data integration, analysis and collaboration
  publication-title: BMC Bioinformatics
– volume: 158
  start-page: 163
  year: 2020
  end-page: 181
  ident: bib41
  article-title: A workflow for visualizing human cancer biopsies using large-format electron microscopy
  publication-title: Methods Cell Biol.
– volume: 8
  start-page: 1324
  year: 2017
  ident: bib99
  article-title: Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
  publication-title: Nat. Commun.
– volume: 66
  start-page: 1500
  year: 2006
  end-page: 1508
  ident: bib50
  article-title: mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
  publication-title: Cancer Res.
– volume: 6
  start-page: 39259
  year: 2016
  ident: bib100
  article-title: A cloud-based workflow to quantify transcript-expression levels in public cancer compendia
  publication-title: Sci. Rep.
– volume: 4
  start-page: ra9
  year: 2011
  ident: bib26
  article-title: MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop
  publication-title: Sci. Signal.
– volume: 8
  start-page: e80908.e8
  year: 2013
  ident: bib30
  article-title: Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages
  publication-title: PLoS One
– volume: 11
  start-page: eaav7171
  year: 2019
  ident: bib55
  article-title: MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21
  publication-title: Sci. Transl. Med.
– volume: 6
  start-page: 8390
  year: 2015
  ident: bib40
  article-title: Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method
  publication-title: Nat. Commun.
– volume: 34
  start-page: 525
  year: 2016
  end-page: 527
  ident: bib101
  article-title: Near-optimal probabilistic RNA-seq quantification
  publication-title: Nat. Biotechnol.
– volume: 5
  start-page: 2512
  year: 2006
  end-page: 2521
  ident: bib21
  article-title: Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
  publication-title: Mol. Cancer Ther.
– volume: 2
  start-page: 100257
  year: 2021
  ident: bib25
  article-title: Causal interactions from proteomic profiles: molecular data meet pathway knowledge
  publication-title: Patterns
– volume: 1188
  start-page: 251
  year: 2019
  end-page: 266
  ident: bib20
  article-title: Using reverse phase protein array (RPPA) to identify and target adaptive resistance
  publication-title: Adv. Exp. Med. Biol.
– volume: 71
  start-page: 558
  year: 2019
  end-page: 568
  ident: bib98
  article-title: Statistical inference for the Weitzman overlapping coefficient in a family of distributions
  publication-title: Appl. Math. Model.
– volume: 95
  start-page: 14863
  year: 1998
  end-page: 14868
  ident: bib110
  article-title: Cluster analysis and display of genome-wide expression patterns
  publication-title: Proc. Natl. Acad. Sci. U S A
– volume: 4
  start-page: 1521
  year: 2015
  ident: bib103
  article-title: Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences
  publication-title: F1000Res.
– volume: 351
  start-page: 2817
  year: 2004
  end-page: 2826
  ident: bib6
  article-title: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
  publication-title: N. Engl. J. Med.
– volume: Chapter 14
  start-page: Unit14 20
  year: 2010
  ident: bib83
  article-title: Computer control of microscopes using microManager
  publication-title: Curr. Protoc. Mol. Biol.
– year: 2021
  ident: bib115
  article-title: SMMART-BC
– volume: 2017
  start-page: 672
  year: 2017
  end-page: 675
  ident: bib116
  article-title: Deep learning based nucleus classification in pancreas histological images
  publication-title: Annu. Int. Conf. IEEE Eng. Med. Biol. Soc.
– volume: 5
  start-page: 3887
  year: 2014
  ident: bib108
  article-title: A pan-cancer proteomic perspective on the Cancer Genome Atlas
  publication-title: Nat. Commun.
– ident: bib7
  article-title: Breast cancer (Version 8.2021)
– volume: 572
  start-page: 538
  year: 2019
  end-page: 542
  ident: bib38
  article-title: Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
  publication-title: Nature
– volume: 9
  start-page: 2586
  year: 2014
  end-page: 2606
  ident: bib96
  article-title: Detecting ultralow-frequency mutations by duplex sequencing
  publication-title: Nat. Protoc.
– volume: 12
  start-page: e1004873
  year: 2016
  ident: bib92
  article-title: CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing
  publication-title: PLoS Comput. Biol.
– volume: 181
  start-page: 236
  year: 2020
  end-page: 249
  ident: bib5
  article-title: The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution
  publication-title: Cell
– volume: 19
  start-page: 203
  year: 2017
  end-page: 217
  ident: bib28
  article-title: Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis
  publication-title: Cell Rep.
– volume: 5
  start-page: a003772
  year: 2019
  ident: bib14
  article-title: Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer
  publication-title: Cold Spring Harb. Mol. Case Stud.
– volume: 19
  start-page: 15
  year: 2018
  ident: bib119
  article-title: SCANPY: large-scale single-cell gene expression data analysis
  publication-title: Genome Biol.
– volume: 5
  start-page: 28
  year: 2021
  ident: bib71
  article-title: Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
  publication-title: NPJ Precis Oncol.
– volume: 48
  start-page: D498
  year: 2020
  end-page: D503
  ident: bib107
  article-title: The reactome pathway knowledgebase
  publication-title: Nucleic Acids Res.
– volume: 32
  start-page: 896
  year: 2014
  end-page: 902
  ident: bib105
  article-title: Normalization of RNA-seq data using factor analysis of control genes or samples
  publication-title: Nat. Biotechnol.
– volume: 26
  start-page: 589
  year: 2010
  end-page: 595
  ident: bib87
  article-title: Fast and accurate long-read alignment with Burrows–Wheeler transform
  publication-title: Bioinformatics
– volume: 45
  start-page: 228
  year: 2009
  end-page: 247
  ident: bib8
  article-title: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
  publication-title: Eur. J. Cancer
– volume: 10
  start-page: 3533
  year: 2019
  end-page: 3546
  ident: bib22
  article-title: Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options
  publication-title: Oncotarget
– volume: 2055
  start-page: 521
  year: 2020
  end-page: 562
  ident: bib39
  article-title: Cyclic multiplexed-immunofluorescence (cmIF), a highly multiplexed method for single-cell analysis
  publication-title: Methods Mol. Biol.
– volume: 124
  start-page: 3733
  year: 2011
  end-page: 3741
  ident: bib42
  article-title: Myosin-X: a MyTH-FERM myosin at the tips of filopodia
  publication-title: J. Cell Sci
– volume: 6
  start-page: 13962
  year: 2015
  end-page: 13977
  ident: bib49
  article-title: AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis
  publication-title: Oncotarget
– volume: 10
  start-page: 614288
  year: 2020
  ident: bib70
  article-title: Propranolol sensitizes vascular sarcoma cells to doxorubicin by altering lysosomal drug sequestration and drug efflux
  publication-title: Front. Oncol.
– volume: 21
  start-page: 5497
  year: 2020
  ident: bib31
  article-title: Targeting of CD163(+) macrophages in inflammatory and Malignant diseases
  publication-title: Int. J. Mol. Sci.
– volume: 9
  start-page: 671
  year: 2012
  end-page: 675
  ident: bib81
  article-title: NIH Image to ImageJ: 25 years of image analysis
  publication-title: Nat. Methods
– volume: 33
  start-page: 3817
  year: 2015
  end-page: 3825
  ident: bib2
  article-title: Impact of precision medicine in diverse cancers: a meta-analysis of phase II clinical trials
  publication-title: J. Clin. Oncol.
– volume: 15
  start-page: 458
  year: 2018
  end-page: 469
  ident: bib58
  article-title: When worlds collide: Th17 and Treg cells in cancer and autoimmunity
  publication-title: Cell Mol. Immunol.
– volume: 36
  start-page: 1631
  year: 2018
  end-page: 1641
  ident: bib77
  article-title: Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review
  publication-title: J. Clin. Oncol.
– volume: 17
  start-page: 1245
  year: 2018
  end-page: 1258
  ident: bib23
  article-title: Implementation of a multiplex and quantitative proteomics platform for assessing protein lysates using DNA-barcoded antibodies
  publication-title: Mol. Cell Proteomics
– volume: 35
  start-page: 526
  year: 2019
  end-page: 528
  ident: bib91
  article-title: Ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R
  publication-title: Bioinformatics
– volume: 16
  start-page: 431
  year: 2016
  end-page: 446
  ident: bib36
  article-title: Neutrophils in cancer: neutral no more
  publication-title: Nat. Rev. Cancer
– volume: 11
  start-page: 73
  year: 2021
  ident: bib97
  article-title: The feasibility of patient-specific circulating tumor DNA monitoring throughout multi-modality therapy for locally advanced esophageal and rectal cancer: a potential biomarker for early detection of subclinical disease
  publication-title: Diagnostics
– year: 2019
  ident: bib79
  article-title: Post-fixation heavy metal staining and resin embedding for electron microscopy (EM)
– volume: 7
  start-page: 40766
  year: 2017
  ident: bib43
  article-title: Superresolution imaging of clinical formalin fixed paraffin embedded breast cancer with single molecule localization microscopy
  publication-title: Sci. Rep.
– volume: 107
  start-page: 216
  year: 2017
  end-page: 227
  ident: bib63
  article-title: DNA damage related crosstalk between the nucleus and mitochondria
  publication-title: Free Radic. Biol. Med.
– volume: 8
  start-page: 118
  year: 2007
  end-page: 127
  ident: bib118
  article-title: Adjusting batch effects in microarray expression data using empirical Bayes methods
  publication-title: Biostatistics
– volume: 28
  start-page: 4877
  year: 2010
  end-page: 4883
  ident: bib1
  article-title: Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers
  publication-title: J. Clin. Oncol.
– volume: 6
  start-page: eabb2210
  year: 2020
  ident: bib67
  article-title: Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition
  publication-title: Sci. Adv.
– volume: 162
  start-page: 259
  year: 2015
  end-page: 270
  ident: bib64
  article-title: The utilization of extracellular proteins as nutrients is suppressed by mTORC1
  publication-title: Cell
– volume: 10
  start-page: 4907
  year: 2019
  end-page: 4918
  ident: bib54
  article-title: The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer
  publication-title: Oncotarget
– volume: 351
  start-page: 1463
  year: 2016
  end-page: 1469
  ident: bib12
  article-title: Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
  publication-title: Science
– volume: 75
  start-page: 5341
  year: 2015
  end-page: 5354
  ident: bib9
  article-title: Identification of variant-specific functions of PIK3CA by rapid phenotyping of rare mutations
  publication-title: Cancer Res.
– volume: 27
  start-page: 1160
  year: 2009
  end-page: 1167
  ident: bib15
  article-title: Supervised risk predictor of breast cancer based on intrinsic subtypes
  publication-title: J. Clin. Oncol.
– volume: 24
  start-page: 2605
  year: 2018
  end-page: 2615
  ident: bib57
  article-title: Capecitabine efficacy is correlated with TYMP and RB1 expression in PDX established from triple-negative breast cancers
  publication-title: Clin. Cancer Res.
– volume: 490
  start-page: 61
  year: 2012
  end-page: 70
  ident: bib16
  article-title: Comprehensive molecular portraits of human breast tumours
  publication-title: Nature
– volume: 27
  start-page: 2987
  year: 2011
  end-page: 2993
  ident: bib90
  article-title: A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data
  publication-title: Bioinformatics
– volume: 33
  start-page: 450
  year: 2018
  end-page: 462.e410
  ident: bib10
  article-title: Systematic functional annotation of somatic mutations in cancer
  publication-title: Cancer Cell
– volume: 20
  start-page: 3246
  year: 2004
  end-page: 3248
  ident: bib109
  article-title: Java Treeview--extensible visualization of microarray data
  publication-title: Bioinformatics
– volume: 37
  start-page: 496
  year: 2020
  end-page: 513
  ident: bib47
  article-title: Overcoming endocrine resistance in breast cancer
  publication-title: Cancer Cell
– volume: 53
  start-page: 5
  year: 2016
  end-page: 15
  ident: bib85
  article-title: Observer variability in RECIST-based tumour burden measurements: a meta-analysis
  publication-title: Eur. J. Cancer
– year: 2020
  ident: bib78
  article-title: Sample fixation of biopsy tissue for Electron Microscopy (EM)
– volume: 14
  start-page: e1002340
  year: 2016
  ident: bib82
  article-title: Microscopy image browser: a platform for segmentation and analysis of multidimensional datasets
  publication-title: Plos Biol.
– volume: 548
  start-page: 471
  year: 2017
  end-page: 475
  ident: bib59
  article-title: CDK4/6 inhibition triggers anti-tumour immunity
  publication-title: Nature
– volume: 95
  start-page: 389
  year: 2019
  end-page: 398
  ident: bib29
  article-title: Robust cell detection and segmentation for image cytometry reveal Th17 cell heterogeneity
  publication-title: Cytometry A
– volume: 30
  start-page: 3310
  year: 2014
  end-page: 3316
  ident: bib94
  article-title: OptiType: precision HLA typing from next-generation sequencing data
  publication-title: Bioinformatics
– volume: 17
  start-page: 261
  year: 2020
  end-page: 272
  ident: bib122
  article-title: SciPy 1.0: fundamental algorithms for scientific computing in Python
  publication-title: Nat. Methods
– volume: 36
  start-page: 540
  year: 2016
  end-page: 549
  ident: bib45
  article-title: Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells
  publication-title: Dev. Cell
– volume: 12
  start-page: 394
  year: 2021
  end-page: 400
  ident: bib11
  article-title: Tumor mutational burden as a predictor of immunotherapy response in breast cancer
  publication-title: Oncotarget
– volume: 36
  start-page: 713
  year: 2020
  end-page: 720
  ident: bib93
  article-title: Neoepiscope improves neoepitope prediction with multivariant phasing
  publication-title: Bioinformatics
– volume: 18
  start-page: S15
  year: 2019
  end-page: S25
  ident: bib19
  article-title: TCPA v3.0: an integrative platform to explore the pan-cancer analysis of functional proteomic data
  publication-title: Mol. Cell Proteomics
– volume: 16
  start-page: 358
  year: 2018
  ident: bib4
  article-title: Implementing a comprehensive translational oncology platform: from molecular testing to actionability
  publication-title: J. Transl. Med.
– volume: 106
  start-page: e53154
  year: 2015
  ident: bib84
  article-title: Photoactivated localization microscopy with bimolecular fluorescence complementation (BiFC-PALM)
  publication-title: J. Vis. Exp.
– volume: 60
  start-page: 608
  year: 2019
  end-page: 614
  ident: bib86
  article-title: Test-retest reproducibility of (18)F-FDG PET/CT uptake in cancer patients within a qualified and calibrated local network
  publication-title: J. Nucl. Med.
– year: 2021
  ident: bib112
  article-title: HTAN multiplex IHC image cytometry V0.1
– volume: 20
  start-page: 1297
  year: 2010
  end-page: 1303
  ident: bib88
  article-title: The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data
  publication-title: Genome Res.
– volume: 497
  start-page: 633
  year: 2013
  end-page: 637
  ident: bib44
  article-title: Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
  publication-title: Nature
– volume: 8
  start-page: 361ra138
  year: 2016
  ident: bib35
  article-title: Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
  publication-title: Sci. Transl Med.
– volume: 635
  start-page: 1
  year: 2020
  end-page: 20
  ident: bib27
  article-title: High-dimensional multiplexed immunohistochemical characterization of immune contexture in human cancers
  publication-title: Methods Enzymol.
– volume: 16
  start-page: e2005970
  year: 2018
  ident: bib114
  article-title: CellProfiler 3.0: next-generation image processing for biology
  publication-title: PLoS Biol.
– volume: 376
  start-page: 294
  year: 2021
  end-page: 305
  ident: bib69
  article-title: Lysosomal biogenesis and implications for hydroxychloroquine disposition
  publication-title: J. Pharmacol. Exp. Ther.
– volume: 18
  start-page: 1525
  year: 2017
  end-page: 1539
  ident: bib3
  article-title: Precision oncology: neither a silver bullet nor a dream
  publication-title: Pharmacogenomics
– volume: 12
  start-page: 391
  year: 2013
  end-page: 402
  ident: bib32
  article-title: Diagnostic and prognostic potential of the macrophage specific receptor CD163 in inflammatory diseases
  publication-title: Inflamm. Allergy Drug Targets
– volume: 76
  start-page: 2301
  year: 2016
  end-page: 2313
  ident: bib53
  article-title: Early adaptation and acquired resistance to CDK4/6 inhibition in Estrogen receptor-positive breast cancer
  publication-title: Cancer Res.
– volume: 9
  start-page: 245
  year: 2012
  end-page: 253
  ident: bib76
  article-title: OMERO: flexible, model-driven data management for experimental biology
  publication-title: Nat. Methods
– volume: 26
  start-page: 1067
  year: 2019
  end-page: 1080.e1068
  ident: bib56
  article-title: Multiomics profiling establishes the polypharmacology of FDA-approved CDK4/6 inhibitors and the potential for differential clinical activity
  publication-title: Cell Chem. Biol.
– volume: 28
  start-page: 882
  year: 2012
  end-page: 883
  ident: bib106
  article-title: The sva package for removing batch effects and other unwanted variation in high-throughput experiments
  publication-title: Bioinformatics
– volume: 36
  start-page: 265
  year: 2015
  end-page: 276
  ident: bib33
  article-title: Overcoming T cell exhaustion in infection and cancer
  publication-title: Trends Immunol.
– volume: 39
  start-page: D685
  year: 2011
  end-page: D690
  ident: bib24
  article-title: Pathway Commons, a web resource for biological pathway data
  publication-title: Nucleic Acids Res.
– year: 2019
  ident: bib121
  article-title: napari: a multi-dimensional image viewer for python
– volume: 113
  start-page: 31
  year: 2019
  end-page: 37
  ident: bib65
  article-title: Dysfunction of antigen processing and presentation by dendritic cells in cancer
  publication-title: Mol. Immunol.
– volume: 46
  start-page: W537
  year: 2018
  end-page: W544
  ident: bib75
  article-title: The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update
  publication-title: Nucleic Acids Res.
– volume: 8
  start-page: 118
  year: 2007
  ident: 10.1016/j.xcrm.2022.100525_bib118
  article-title: Adjusting batch effects in microarray expression data using empirical Bayes methods
  publication-title: Biostatistics
  doi: 10.1093/biostatistics/kxj037
– volume: 36
  start-page: 1631
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib77
  article-title: Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2017.76.8671
– volume: 18
  start-page: 215
  year: 2021
  ident: 10.1016/j.xcrm.2022.100525_bib13
  article-title: Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
  publication-title: Nat. Rev. Clin. Oncol.
  doi: 10.1038/s41571-020-00460-2
– volume: 27
  start-page: 2987
  year: 2011
  ident: 10.1016/j.xcrm.2022.100525_bib90
  article-title: A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btr509
– volume: 9
  start-page: 666
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib48
  article-title: Mechanisms of resistance to CDK4/6 inhibitors: potential implications and biomarkers for clinical practice
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2019.00666
– volume: 19
  start-page: 2
  year: 2017
  ident: 10.1016/j.xcrm.2022.100525_bib37
  article-title: Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
  publication-title: Breast Cancer Res.
  doi: 10.1186/s13058-016-0794-1
– volume: 572
  start-page: 538
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib38
  article-title: Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
  publication-title: Nature
  doi: 10.1038/s41586-019-1450-6
– volume: 124
  start-page: 3733
  year: 2011
  ident: 10.1016/j.xcrm.2022.100525_bib42
  article-title: Myosin-X: a MyTH-FERM myosin at the tips of filopodia
  publication-title: J. Cell Sci
  doi: 10.1242/jcs.023549
– volume: 2055
  start-page: 521
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib39
  article-title: Cyclic multiplexed-immunofluorescence (cmIF), a highly multiplexed method for single-cell analysis
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-9773-2_24
– volume: 95
  start-page: 389
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib29
  article-title: Robust cell detection and segmentation for image cytometry reveal Th17 cell heterogeneity
  publication-title: Cytometry A
  doi: 10.1002/cyto.a.23726
– volume: 548
  start-page: 471
  year: 2017
  ident: 10.1016/j.xcrm.2022.100525_bib59
  article-title: CDK4/6 inhibition triggers anti-tumour immunity
  publication-title: Nature
  doi: 10.1038/nature23465
– volume: 36
  start-page: 265
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib33
  article-title: Overcoming T cell exhaustion in infection and cancer
  publication-title: Trends Immunol.
  doi: 10.1016/j.it.2015.02.008
– volume: 14
  start-page: 7
  year: 2013
  ident: 10.1016/j.xcrm.2022.100525_bib17
  article-title: GSVA: gene set variation analysis for microarray and RNA-seq data
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-14-7
– volume: 76
  start-page: 2301
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib53
  article-title: Early adaptation and acquired resistance to CDK4/6 inhibition in Estrogen receptor-positive breast cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-15-0728
– volume: 15
  start-page: 458
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib58
  article-title: When worlds collide: Th17 and Treg cells in cancer and autoimmunity
  publication-title: Cell Mol. Immunol.
  doi: 10.1038/s41423-018-0004-4
– volume: 351
  start-page: 2817
  year: 2004
  ident: 10.1016/j.xcrm.2022.100525_bib6
  article-title: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa041588
– year: 2021
  ident: 10.1016/j.xcrm.2022.100525_bib112
– volume: 28
  start-page: 882
  year: 2012
  ident: 10.1016/j.xcrm.2022.100525_bib106
  article-title: The sva package for removing batch effects and other unwanted variation in high-throughput experiments
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bts034
– volume: 46
  start-page: W537
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib75
  article-title: The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gky379
– volume: 48
  start-page: D498
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib107
  article-title: The reactome pathway knowledgebase
  publication-title: Nucleic Acids Res.
– volume: 71
  start-page: 558
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib98
  article-title: Statistical inference for the Weitzman overlapping coefficient in a family of distributions
  publication-title: Appl. Math. Model.
  doi: 10.1016/j.apm.2019.02.036
– volume: 16
  start-page: 358
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib4
  article-title: Implementing a comprehensive translational oncology platform: from molecular testing to actionability
  publication-title: J. Transl. Med.
  doi: 10.1186/s12967-018-1733-y
– volume: 6
  start-page: 353
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib52
  article-title: Targeting CDK4 and CDK6: from discovery to therapy
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-15-0894
– volume: 181
  start-page: 236
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib5
  article-title: The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution
  publication-title: Cell
  doi: 10.1016/j.cell.2020.03.053
– volume: 18
  start-page: 100
  year: 2021
  ident: 10.1016/j.xcrm.2022.100525_bib117
  article-title: Cellpose: a generalist algorithm for cellular segmentation
  publication-title: Nat. Methods
  doi: 10.1038/s41592-020-01018-x
– volume: 30
  start-page: 3310
  year: 2014
  ident: 10.1016/j.xcrm.2022.100525_bib94
  article-title: OptiType: precision HLA typing from next-generation sequencing data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu548
– volume: 490
  start-page: 61
  year: 2012
  ident: 10.1016/j.xcrm.2022.100525_bib16
  article-title: Comprehensive molecular portraits of human breast tumours
  publication-title: Nature
  doi: 10.1038/nature11412
– volume: 17
  start-page: 261
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib122
  article-title: SciPy 1.0: fundamental algorithms for scientific computing in Python
  publication-title: Nat. Methods
  doi: 10.1038/s41592-019-0686-2
– volume: 9
  start-page: 245
  year: 2012
  ident: 10.1016/j.xcrm.2022.100525_bib76
  article-title: OMERO: flexible, model-driven data management for experimental biology
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.1896
– volume: 26
  start-page: 589
  year: 2010
  ident: 10.1016/j.xcrm.2022.100525_bib87
  article-title: Fast and accurate long-read alignment with Burrows–Wheeler transform
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp698
– volume: 13
  start-page: 443
  year: 2017
  ident: 10.1016/j.xcrm.2022.100525_bib62
  article-title: Crosstalk between the nucleolus and the DNA damage response
  publication-title: Mol. Biosyst.
  doi: 10.1039/C6MB00740F
– volume: 11
  start-page: eaav7171
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib55
  article-title: MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21
  publication-title: Sci. Transl. Med.
  doi: 10.1126/scitranslmed.aav7171
– volume: 42
  start-page: 1460
  year: 2014
  ident: 10.1016/j.xcrm.2022.100525_bib66
  article-title: Lysosomotropic agents: impact on lysosomal membrane permeabilization and cell death
  publication-title: Biochem. Soc. Trans.
  doi: 10.1042/BST20140145
– volume: 19
  start-page: 15
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib119
  article-title: SCANPY: large-scale single-cell gene expression data analysis
  publication-title: Genome Biol.
  doi: 10.1186/s13059-017-1382-0
– volume: 75
  start-page: 5341
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib9
  article-title: Identification of variant-specific functions of PIK3CA by rapid phenotyping of rare mutations
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-15-1654
– volume: 37
  start-page: 496
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib47
  article-title: Overcoming endocrine resistance in breast cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2020.03.009
– volume: 17
  start-page: 1245
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib23
  article-title: Implementation of a multiplex and quantitative proteomics platform for assessing protein lysates using DNA-barcoded antibodies
  publication-title: Mol. Cell Proteomics
  doi: 10.1074/mcp.RA117.000291
– volume: 376
  start-page: 294
  year: 2021
  ident: 10.1016/j.xcrm.2022.100525_bib69
  article-title: Lysosomal biogenesis and implications for hydroxychloroquine disposition
  publication-title: J. Pharmacol. Exp. Ther.
  doi: 10.1124/jpet.120.000309
– volume: 35
  start-page: 526
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib91
  article-title: Ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bty633
– volume: 6
  start-page: 39259
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib100
  article-title: A cloud-based workflow to quantify transcript-expression levels in public cancer compendia
  publication-title: Sci. Rep.
  doi: 10.1038/srep39259
– volume: 14
  start-page: e1002340
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib82
  article-title: Microscopy image browser: a platform for segmentation and analysis of multidimensional datasets
  publication-title: Plos Biol.
  doi: 10.1371/journal.pbio.1002340
– volume: 158
  start-page: 163
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib41
  article-title: A workflow for visualizing human cancer biopsies using large-format electron microscopy
  publication-title: Methods Cell Biol.
  doi: 10.1016/bs.mcb.2020.01.005
– volume: 106
  start-page: e53154
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib84
  article-title: Photoactivated localization microscopy with bimolecular fluorescence complementation (BiFC-PALM)
  publication-title: J. Vis. Exp.
– volume: 8
  start-page: 1324
  year: 2017
  ident: 10.1016/j.xcrm.2022.100525_bib99
  article-title: Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-00965-y
– volume: 10
  start-page: 614288
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib70
  article-title: Propranolol sensitizes vascular sarcoma cells to doxorubicin by altering lysosomal drug sequestration and drug efflux
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2020.614288
– volume: 10
  start-page: 3533
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib22
  article-title: Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.26947
– volume: 2017
  start-page: 672
  year: 2017
  ident: 10.1016/j.xcrm.2022.100525_bib116
  article-title: Deep learning based nucleus classification in pancreas histological images
  publication-title: Annu. Int. Conf. IEEE Eng. Med. Biol. Soc.
– volume: 12
  start-page: 394
  year: 2021
  ident: 10.1016/j.xcrm.2022.100525_bib11
  article-title: Tumor mutational burden as a predictor of immunotherapy response in breast cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.27877
– volume: 1
  start-page: 417
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib18
  article-title: The Molecular Signatures Database (MSigDB) hallmark gene set collection
  publication-title: Cell Syst.
  doi: 10.1016/j.cels.2015.12.004
– volume: 6
  start-page: eabb2210
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib67
  article-title: Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.abb2210
– volume: 113
  start-page: 31
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib65
  article-title: Dysfunction of antigen processing and presentation by dendritic cells in cancer
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2018.03.025
– volume: 43
  start-page: 7664
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib104
  article-title: How data analysis affects power, reproducibility and biological insight of RNA-seq studies in complex datasets
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkv736
– year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib78
– volume: 107
  start-page: 216
  year: 2017
  ident: 10.1016/j.xcrm.2022.100525_bib63
  article-title: DNA damage related crosstalk between the nucleus and mitochondria
  publication-title: Free Radic. Biol. Med.
  doi: 10.1016/j.freeradbiomed.2016.11.050
– volume: 6
  start-page: 13962
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib49
  article-title: AKT inhibition overcomes rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1/4E-BP1 axis
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3920
– volume: 7
  start-page: 1120
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib60
  article-title: Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration
  publication-title: Integr. Biol.
  doi: 10.1039/c5ib00040h
– volume: 2
  start-page: 100257
  year: 2021
  ident: 10.1016/j.xcrm.2022.100525_bib25
  article-title: Causal interactions from proteomic profiles: molecular data meet pathway knowledge
  publication-title: Patterns
  doi: 10.1016/j.patter.2021.100257
– volume: 5
  start-page: 3887
  year: 2014
  ident: 10.1016/j.xcrm.2022.100525_bib108
  article-title: A pan-cancer proteomic perspective on the Cancer Genome Atlas
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms4887
– volume: 27
  start-page: 4177
  year: 2021
  ident: 10.1016/j.xcrm.2022.100525_bib72
  article-title: Phase I/II trial of exemestane, ribociclib, and everolimus in women with HR(+)/HER2(-) advanced breast cancer after progression on CDK4/6 inhibitors (TRINITI-1)
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-20-2114
– volume: 9
  start-page: 2586
  year: 2014
  ident: 10.1016/j.xcrm.2022.100525_bib96
  article-title: Detecting ultralow-frequency mutations by duplex sequencing
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2014.170
– volume: 6
  start-page: 8390
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib40
  article-title: Highly multiplexed imaging of single cells using a high-throughput cyclic immunofluorescence method
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms9390
– volume: 351
  start-page: 1463
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib12
  article-title: Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
  publication-title: Science
  doi: 10.1126/science.aaf1490
– volume: 12
  start-page: 391
  year: 2013
  ident: 10.1016/j.xcrm.2022.100525_bib32
  article-title: Diagnostic and prognostic potential of the macrophage specific receptor CD163 in inflammatory diseases
  publication-title: Inflamm. Allergy Drug Targets
  doi: 10.2174/18715281113126660060
– volume: 18
  start-page: S15
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib19
  article-title: TCPA v3.0: an integrative platform to explore the pan-cancer analysis of functional proteomic data
  publication-title: Mol. Cell Proteomics
  doi: 10.1074/mcp.RA118.001260
– volume: 34
  start-page: 427
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib46
  article-title: The genomic landscape of endocrine-resistant advanced breast cancers
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2018.08.008
– volume: 7
  start-page: 40766
  year: 2017
  ident: 10.1016/j.xcrm.2022.100525_bib43
  article-title: Superresolution imaging of clinical formalin fixed paraffin embedded breast cancer with single molecule localization microscopy
  publication-title: Sci. Rep.
  doi: 10.1038/srep40766
– volume: 102
  start-page: 802
  year: 2005
  ident: 10.1016/j.xcrm.2022.100525_bib51
  article-title: Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
  publication-title: Proc. Natl. Acad. Sci. U S A
  doi: 10.1073/pnas.0408864102
– volume: 581
  start-page: 434
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib89
  article-title: The mutational constraint spectrum quantified from variation in 141,456 humans
  publication-title: Nature
  doi: 10.1038/s41586-020-2308-7
– volume: 36
  start-page: 540
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib45
  article-title: Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2016.02.012
– year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib79
– volume: 18
  start-page: 1525
  year: 2017
  ident: 10.1016/j.xcrm.2022.100525_bib3
  article-title: Precision oncology: neither a silver bullet nor a dream
  publication-title: Pharmacogenomics
  doi: 10.2217/pgs-2017-0094
– volume: 28
  start-page: 4877
  year: 2010
  ident: 10.1016/j.xcrm.2022.100525_bib1
  article-title: Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2009.26.5983
– volume: 1188
  start-page: 251
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib20
  article-title: Using reverse phase protein array (RPPA) to identify and target adaptive resistance
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-981-32-9755-5_14
– volume: 19
  start-page: 203
  year: 2017
  ident: 10.1016/j.xcrm.2022.100525_bib28
  article-title: Quantitative multiplex immunohistochemistry reveals myeloid-inflamed tumor-immune complexity associated with poor prognosis
  publication-title: Cell Rep.
  doi: 10.1016/j.celrep.2017.03.037
– volume: 8
  start-page: 361ra138
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib35
  article-title: Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps
  publication-title: Sci. Transl Med.
  doi: 10.1126/scitranslmed.aag1711
– volume: 16
  start-page: e2005970
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib114
  article-title: CellProfiler 3.0: next-generation image processing for biology
  publication-title: PLoS Biol.
  doi: 10.1371/journal.pbio.2005970
– volume: 12
  start-page: 71
  year: 2011
  ident: 10.1016/j.xcrm.2022.100525_bib74
  article-title: LabKey Server: an open source platform for scientific data integration, analysis and collaboration
  publication-title: BMC Bioinformatics
  doi: 10.1186/1471-2105-12-71
– volume: 497
  start-page: 633
  year: 2013
  ident: 10.1016/j.xcrm.2022.100525_bib44
  article-title: Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells
  publication-title: Nature
  doi: 10.1038/nature12138
– volume: 16
  start-page: 431
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib36
  article-title: Neutrophils in cancer: neutral no more
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc.2016.52
– volume: 5
  start-page: a003772
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib14
  article-title: Circulating tumor DNA dynamics using patient-customized assays are associated with outcome in neoadjuvantly treated breast cancer
  publication-title: Cold Spring Harb. Mol. Case Stud.
  doi: 10.1101/mcs.a003772
– volume: 25
  start-page: 920
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib73
  article-title: Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial
  publication-title: Nat. Med.
  doi: 10.1038/s41591-019-0432-4
– volume: 7
  start-page: 129
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib95
  article-title: MHCflurry: open-source class I MHC binding affinity prediction
  publication-title: Cell Syst.
  doi: 10.1016/j.cels.2018.05.014
– volume: 32
  start-page: 896
  year: 2014
  ident: 10.1016/j.xcrm.2022.100525_bib105
  article-title: Normalization of RNA-seq data using factor analysis of control genes or samples
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.2931
– volume: 4
  start-page: 1521
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib103
  article-title: Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences
  publication-title: F1000Res.
  doi: 10.12688/f1000research.7563.1
– volume: 8
  start-page: e80908.e8
  year: 2013
  ident: 10.1016/j.xcrm.2022.100525_bib30
  article-title: Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0080908
– volume: Chapter 14
  start-page: Unit14 20
  year: 2010
  ident: 10.1016/j.xcrm.2022.100525_bib83
  article-title: Computer control of microscopes using microManager
  publication-title: Curr. Protoc. Mol. Biol.
– volume: 5
  start-page: 28
  year: 2021
  ident: 10.1016/j.xcrm.2022.100525_bib71
  article-title: Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics
  publication-title: NPJ Precis Oncol.
  doi: 10.1038/s41698-021-00165-4
– volume: 47
  start-page: D766
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib102
  article-title: GENCODE reference annotation for the human and mouse genomes
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gky955
– volume: 24
  start-page: 2605
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib57
  article-title: Capecitabine efficacy is correlated with TYMP and RB1 expression in PDX established from triple-negative breast cancers
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-17-3490
– volume: 8
  start-page: 9484
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib61
  article-title: Chemotherapy-induced tunneling nanotubes mediate intercellular drug efflux in pancreatic cancer
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-27649-x
– year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib121
– volume: 9
  start-page: 5233
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib120
  article-title: From Louvain to Leiden: guaranteeing well-connected communities
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-019-41695-z
– volume: 10
  start-page: 4907
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib54
  article-title: The p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.27127
– volume: 34
  start-page: 525
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib101
  article-title: Near-optimal probabilistic RNA-seq quantification
  publication-title: Nat. Biotechnol.
  doi: 10.1038/nbt.3519
– volume: 361
  start-page: eaao4227
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib34
  article-title: Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
  publication-title: Science
  doi: 10.1126/science.aao4227
– volume: 21
  start-page: 5497
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib31
  article-title: Targeting of CD163(+) macrophages in inflammatory and Malignant diseases
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21155497
– volume: 38
  start-page: 3886
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib68
  article-title: Lysosomal trapping of palbociclib and its functional implications
  publication-title: Oncogene
  doi: 10.1038/s41388-019-0695-8
– volume: 33
  start-page: 3817
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib2
  article-title: Impact of precision medicine in diverse cancers: a meta-analysis of phase II clinical trials
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2015.61.5997
– volume: 26
  start-page: 1067
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib56
  article-title: Multiomics profiling establishes the polypharmacology of FDA-approved CDK4/6 inhibitors and the potential for differential clinical activity
  publication-title: Cell Chem. Biol.
  doi: 10.1016/j.chembiol.2019.05.005
– volume: 45
  start-page: 228
  year: 2009
  ident: 10.1016/j.xcrm.2022.100525_bib8
  article-title: New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
  publication-title: Eur. J. Cancer
  doi: 10.1016/j.ejca.2008.10.026
– volume: 5
  start-page: 2512
  year: 2006
  ident: 10.1016/j.xcrm.2022.100525_bib21
  article-title: Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-06-0334
– volume: 635
  start-page: 1
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib27
  article-title: High-dimensional multiplexed immunohistochemical characterization of immune contexture in human cancers
  publication-title: Methods Enzymol.
  doi: 10.1016/bs.mie.2019.05.039
– volume: 53
  start-page: 5
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib85
  article-title: Observer variability in RECIST-based tumour burden measurements: a meta-analysis
  publication-title: Eur. J. Cancer
  doi: 10.1016/j.ejca.2015.10.014
– volume: 27
  start-page: 1160
  year: 2009
  ident: 10.1016/j.xcrm.2022.100525_bib15
  article-title: Supervised risk predictor of breast cancer based on intrinsic subtypes
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2008.18.1370
– volume: 11
  start-page: 73
  year: 2021
  ident: 10.1016/j.xcrm.2022.100525_bib97
  article-title: The feasibility of patient-specific circulating tumor DNA monitoring throughout multi-modality therapy for locally advanced esophageal and rectal cancer: a potential biomarker for early detection of subclinical disease
  publication-title: Diagnostics
  doi: 10.3390/diagnostics11010073
– volume: 95
  start-page: 14863
  year: 1998
  ident: 10.1016/j.xcrm.2022.100525_bib110
  article-title: Cluster analysis and display of genome-wide expression patterns
  publication-title: Proc. Natl. Acad. Sci. U S A
  doi: 10.1073/pnas.95.25.14863
– volume: 36
  start-page: 713
  year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib93
  article-title: Neoepiscope improves neoepitope prediction with multivariant phasing
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btz653
– year: 2020
  ident: 10.1016/j.xcrm.2022.100525_bib80
– volume: 110
  start-page: 346
  year: 2008
  ident: 10.1016/j.xcrm.2022.100525_bib113
  article-title: Speeded-up robust features (SURF)
  publication-title: Comput. Vis. Image Understand.
  doi: 10.1016/j.cviu.2007.09.014
– volume: 60
  start-page: 608
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib86
  article-title: Test-retest reproducibility of (18)F-FDG PET/CT uptake in cancer patients within a qualified and calibrated local network
  publication-title: J. Nucl. Med.
  doi: 10.2967/jnumed.118.209544
– volume: 33
  start-page: 450
  year: 2018
  ident: 10.1016/j.xcrm.2022.100525_bib10
  article-title: Systematic functional annotation of somatic mutations in cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2018.01.021
– volume: 66
  start-page: 1500
  year: 2006
  ident: 10.1016/j.xcrm.2022.100525_bib50
  article-title: mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-05-2925
– volume: 20
  start-page: 3246
  year: 2004
  ident: 10.1016/j.xcrm.2022.100525_bib109
  article-title: Java Treeview--extensible visualization of microarray data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bth349
– volume: 4
  start-page: ra9
  year: 2011
  ident: 10.1016/j.xcrm.2022.100525_bib26
  article-title: MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop
  publication-title: Sci. Signal.
  doi: 10.1126/scisignal.2001426
– volume: 12
  start-page: e1004873
  year: 2016
  ident: 10.1016/j.xcrm.2022.100525_bib92
  article-title: CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing
  publication-title: PLoS Comput. Biol.
  doi: 10.1371/journal.pcbi.1004873
– volume: 39
  start-page: D685
  year: 2011
  ident: 10.1016/j.xcrm.2022.100525_bib24
  article-title: Pathway Commons, a web resource for biological pathway data
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkq1039
– volume: 9
  start-page: 671
  year: 2012
  ident: 10.1016/j.xcrm.2022.100525_bib81
  article-title: NIH Image to ImageJ: 25 years of image analysis
  publication-title: Nat. Methods
  doi: 10.1038/nmeth.2089
– volume: 47
  start-page: 6073
  year: 2019
  ident: 10.1016/j.xcrm.2022.100525_bib111
  article-title: A new normalization for Nanostring nCounter gene expression data
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkz433
– volume: 20
  start-page: 1297
  year: 2010
  ident: 10.1016/j.xcrm.2022.100525_bib88
  article-title: The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data
  publication-title: Genome Res.
  doi: 10.1101/gr.107524.110
– volume: 162
  start-page: 259
  year: 2015
  ident: 10.1016/j.xcrm.2022.100525_bib64
  article-title: The utilization of extracellular proteins as nutrients is suppressed by mTORC1
  publication-title: Cell
  doi: 10.1016/j.cell.2015.06.017
– ident: 10.1016/j.xcrm.2022.100525_bib115
– reference: 35243426 - Cell Rep Med. 2022 Feb 15;3(2):100532. doi: 10.1016/j.xcrm.2022.100532
SSID ssj0002511830
Score 2.3654125
Snippet Mechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change during...
SummaryMechanisms of therapeutic resistance and vulnerability evolve in metastatic cancers as tumor cells and extrinsic microenvironmental influences change...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 100525
SubjectTerms Advanced Basic Science
Biopsy
Breast Neoplasms - genetics
Female
human tumor atlas
Humans
metastatic breast cancer
personalized medicine
precision oncology
Tumor Microenvironment - genetics
Title An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2666379122000258
https://www.clinicalkey.es/playcontent/1-s2.0-S2666379122000258
https://dx.doi.org/10.1016/j.xcrm.2022.100525
https://www.ncbi.nlm.nih.gov/pubmed/35243422
https://www.proquest.com/docview/2636146726
https://pubmed.ncbi.nlm.nih.gov/PMC8861971
Volume 3
WOSCitedRecordID wos000759407600003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2666-3791
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511830
  issn: 2666-3791
  databaseCode: DOA
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2666-3791
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002511830
  issn: 2666-3791
  databaseCode: M~E
  dateStart: 20200101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6gRAviM9RPiYj8Va1apwPO48VGkLTNiFtoL5ZTuJApzatmmwqL_xJ_I3c2U7Slm6wB16iyoldx_fL3fl8H4S8VyA00lQP-yJmvB_wFD4pxQHLgA8l0pBl5sT06wk_OxPjcfy50_lVx8JcT3lRiNUqXvxXUkMbEBtDZ-9A7mZQaIDfQHS4Atnh-k-EH4ECOHNZWI27YIYJ_G3yjV6JDtSYHqACrdnGlthJ9ZLJfFFObApa-OY1sC1ja5jpSmHUEYyYoAN7hX5iqfPprVMcoAHQnT4M7NnP2nG9K8JlkaSrqnc0aE4-cERX1Xo6NdUQT5qb59V8NrNOBMfqByjDp4NWPFgufqxmk6bd2S5g24uVVMKWxYF2EAGLs_W6BnpHm-PR_hoU2Rq_9dCsHe4UBdYqcTlYpUvMOMDYoH14M-_2ljxsvBRrB7hLiWNIHEPaMfbIPcbDGLno6c_Wpme2a6a8TfMSLk7LuhRuT-UmXejPvc62y-6aDnTxmDxymxc6sqB7Qjq6eEoe1PR-Rr6NCorYo4A9uo096rBHDfYoYo9a7NEae3SeQ1daY4-22KMWe9Ri7zn58vHo4sOnvqvk0U9BP6_6QmVpIgIRJAkHnXCowkQNA56rSEcJSDgvz7I49XPOMNQ7hzX0tJf5ZnOh_TzzX5D9Yl7ol4TmiR8NeaJ8HeogYyJJ84wxnQUBCi8WdYlXr6lMXZp7rLYylTeTs0t6TZ-FTfJy69N-TSpZhy-DwJUAvFt78V29dOlYRyk9WTI5lOeIHYQOYwZSokvCpqdTi626-9d_fFfjSILMwINAVej5VSlZ5EeoIeFqHVhcNe8NG7IAGDWD-W4grnkA89Fv3ikm301eeiEiL-beqzut5mvysOUMb8h-tbzSb8n99LqalMtDssfH4tAYyg7Nt_Yb6mcDaA
linkProvider ISSN International Centre
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+omic+and+multidimensional+spatial+atlas+from+serial+biopsies+of+an+evolving+metastatic+breast+cancer&rft.jtitle=Cell+reports.+Medicine&rft.au=Johnson%2C+Brett+E.&rft.au=Creason%2C+Allison+L.&rft.au=Stommel%2C+Jayne+M.&rft.au=Keck%2C+Jamie+M.&rft.date=2022-02-15&rft.issn=2666-3791&rft.eissn=2666-3791&rft.volume=3&rft.issue=2&rft.spage=100525&rft_id=info:doi/10.1016%2Fj.xcrm.2022.100525&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_xcrm_2022_100525
thumbnail_m http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F26663791%2FS2666379121X00031%2Fcov150h.gif